Experienced in MYH9 Related Thrombocytopenia

Dr. Jamile M. Shammo

Hematology | Oncology
Northwestern Medical Group
676 N St Clair St Ste 2140, Arkes Pavilion, 
Chicago, IL 
Offers Telehealth
40 Years of Experience

Experienced in MYH9 Related Thrombocytopenia
Northwestern Medical Group
676 N St Clair St Ste 2140, Arkes Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jamile Shammo is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Shammo has been practicing medicine for over 40 years and is rated as an Experienced provider by MediFind in the treatment of MYH9 Related Thrombocytopenia. Her top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Myelodysplastic Syndrome (MDS), Paroxysmal Cold Hemoglobinuria, Hemolysis, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 41 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of MYH9 Related Thrombocytopenia.

Graduate Institution
University Of Aleppo Faculty Of Medicine, 1985
Residency
McGaw Medical Center of Northwestern University
Specialties
Hematology
Oncology
Licenses
Internal Medicine in IL
Board Certifications
American Board Of Internal Medicine - Hematology (Certified)
Hospital Affiliations
Northwestern Memorial Hospital
Northwestern Lake Forest Hospital
Palos Community Hospital
Northwestern Medicine Central Dupage Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

676 N St Clair St Ste 2140, Arkes Pavilion, Chicago, IL 60611
Call: 866-587-4322

Additional Areas of Focus

Dr. Shammo has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Anemia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

A Phase 3, Randomized, Open-Label, Crossover Study of ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) Versus IV Decitabine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloid Leukemia (AML)
A Phase 3, Randomized, Open-Label, Crossover Study of ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) Versus IV Decitabine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloid Leukemia (AML)
Enrollment Status: Completed
Publish Date: August 27, 2024
Intervention Type: Drug
Study Drugs: Cedazuridine, Decitabine
Study Phase: Phase 3
A Phase III, International, Randomized, Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent
A Phase III, International, Randomized, Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent
Enrollment Status: Terminated
Publish Date: September 26, 2022
Intervention Type: Drug
Study Drug: Rigosertib
Study Phase: Phase 3
A Phase I/II, Multi-center, Dose-escalating Study of the Tolerability, Pharmacokinetics, and Clinical Activity of the Combined Administration of Oral Rigosertib With Azacitidine in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
A Phase I/II, Multi-center, Dose-escalating Study of the Tolerability, Pharmacokinetics, and Clinical Activity of the Combined Administration of Oral Rigosertib With Azacitidine in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Enrollment Status: Completed
Publish Date: June 16, 2021
Intervention Type: Drug
Study Drugs: Rigosertib, Azacitidine
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

41 Total Publications

A Prospective Study of Serum Folate Levels in Patients with Solid Tumors Treated with Olaparib.
A Prospective Study of Serum Folate Levels in Patients with Solid Tumors Treated with Olaparib.
Journal: The oncologist
Published: May 09, 2025
View All 41 Publications
Similar Doctors
Experienced in MYH9 Related Thrombocytopenia
Dr. Yolande Chen
Oncology
Experienced in MYH9 Related Thrombocytopenia
Dr. Yolande Chen
Oncology

The Board Of Trustees Of The University Of Illinois

840 S Wood St Mc, 787 Uic Medicine, 
Chicago, IL 
 (4.0 miles away)
312-413-8687
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Yolande Chen is an Oncologist in Chicago, Illinois. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of MYH9 Related Thrombocytopenia. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Anal Cancer.

VIEW MORE MYH9 RELATED THROMBOCYTOPENIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shammo's expertise for a condition
ConditionClose
  • Elite
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Dr. Shammo is
    Elite
    . Learn about Paroxysmal Nocturnal Hemoglobinuria (PNH).
    See more Paroxysmal Nocturnal Hemoglobinuria (PNH) experts
  • Distinguished
  • Acute Myeloid Leukemia (AML)
    Dr. Shammo is
    Distinguished
    . Learn about Acute Myeloid Leukemia (AML).
    See more Acute Myeloid Leukemia (AML) experts
  • Atypical Hemolytic Uremic Syndrome (aHUS)
    Dr. Shammo is
    Distinguished
    . Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
    See more Atypical Hemolytic Uremic Syndrome (aHUS) experts
  • D-Plus Hemolytic Uremic Syndrome
    Dr. Shammo is
    Distinguished
    . Learn about D-Plus Hemolytic Uremic Syndrome.
    See more D-Plus Hemolytic Uremic Syndrome experts
  • Hemolysis
    Dr. Shammo is
    Distinguished
    . Learn about Hemolysis.
    See more Hemolysis experts
  • Hemolytic-Uremic Syndrome
    Dr. Shammo is
    Distinguished
    . Learn about Hemolytic-Uremic Syndrome.
    See more Hemolytic-Uremic Syndrome experts
  • Myelodysplastic Syndrome (MDS)
    Dr. Shammo is
    Distinguished
    . Learn about Myelodysplastic Syndrome (MDS).
    See more Myelodysplastic Syndrome (MDS) experts
View All 10 Distinguished Conditions
  • Advanced
  • Acute Myeloblastic Leukemia without Maturation
    Dr. Shammo is
    Advanced
    . Learn about Acute Myeloblastic Leukemia without Maturation.
    See more Acute Myeloblastic Leukemia without Maturation experts
  • Adult Immune Thrombocytopenia
    Dr. Shammo is
    Advanced
    . Learn about Adult Immune Thrombocytopenia.
    See more Adult Immune Thrombocytopenia experts
  • Anemia
    Dr. Shammo is
    Advanced
    . Learn about Anemia.
    See more Anemia experts
  • Aplastic Anemia
    Dr. Shammo is
    Advanced
    . Learn about Aplastic Anemia.
    See more Aplastic Anemia experts
  • Bone Marrow Aspiration
    Dr. Shammo is
    Advanced
    . Learn about Bone Marrow Aspiration.
    See more Bone Marrow Aspiration experts
  • Childhood Acute Myeloid Leukemia
    Dr. Shammo is
    Advanced
    . Learn about Childhood Acute Myeloid Leukemia.
    See more Childhood Acute Myeloid Leukemia experts
View All 14 Advanced Conditions
  • Experienced
  • Acute Erythroid Leukemia (AEL)
    Dr. Shammo is
    Experienced
    . Learn about Acute Erythroid Leukemia (AEL).
    See more Acute Erythroid Leukemia (AEL) experts
  • Acute Myeloblastic Leukemia with Maturation
    Dr. Shammo is
    Experienced
    . Learn about Acute Myeloblastic Leukemia with Maturation.
    See more Acute Myeloblastic Leukemia with Maturation experts
  • Agranulocytosis
    Dr. Shammo is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Antiphospholipid Syndrome
    Dr. Shammo is
    Experienced
    . Learn about Antiphospholipid Syndrome.
    See more Antiphospholipid Syndrome experts
  • Ataxia-Pancytopenia Syndrome
    Dr. Shammo is
    Experienced
    . Learn about Ataxia-Pancytopenia Syndrome.
    See more Ataxia-Pancytopenia Syndrome experts
  • B-Cell Lymphoma
    Dr. Shammo is
    Experienced
    . Learn about B-Cell Lymphoma.
    See more B-Cell Lymphoma experts
View All 45 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved